{"altmetric_id":18492471,"counts":{"readers":{"mendeley":0,"citeulike":0,"connotea":0},"total":{"posts_count":5},"twitter":{"unique_users_count":5,"unique_users":["DB_Rein","CLD_Learning","clinicahigado","BruceSchackman","contirena1"],"posts_count":5}},"selected_quotes":["From HepComm: Epid, economic, and budgetary impacts of rates of HCV treatment in medicare and non-medicare pop","Important analysis by @DB_Rein and @NORCNews colleagues #hepC costs Medicare will pay later for deferred treatment now\u2026","Epidemiologic, economic, and budgetary impacts of hepatitis C treatment in medicare and non-medicare populations"],"citation":{"authors":["Wittenborn, John","Brady, Joanne","Dougherty, Michelle","Rein, David"],"doi":"10.1002\/hep4.1031","first_seen_on":"2017-04-04T20:11:18+00:00","issns":["2471254X","2471-254X"],"journal":"Hepatology Communications","last_mentioned_on":1491944202,"links":["http:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hep4.1031\/full"],"pdf_url":"http:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hep4.1031\/pdf","pubdate":"2017-03-31T00:00:00+00:00","title":"Potential epidemiologic, economic, and budgetary impacts of current rates of hepatitis C treatment in medicare and non-medicare populations","type":"article"},"altmetric_score":{"score":4.2,"score_history":{"1y":4.2,"6m":4.2,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":4.2},"context_for_score":null},"demographics":{"poster_types":{"member_of_the_public":2,"researcher":2,"practitioner":1},"users":{"twitter":{"cohorts":{"Members of the public":2,"Practitioners (doctors, other healthcare professionals)":1,"Scientists":2}}},"geo":{"twitter":{"MX":1,"US":2}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/DB_Rein\/statuses\/851502569537097728","license":"gnip","citation_ids":[18492471],"posted_on":"2017-04-10T18:30:07+00:00","author":{"name":"David B. Rein","image":"https:\/\/pbs.twimg.com\/profile_images\/686272043105439744\/WI7D963v_normal.jpg","id_on_source":"DB_Rein","tweeter_id":"4735378818","geo":{"lt":null,"ln":null},"followers":17},"tweet_id":"851502569537097728"},{"url":"http:\/\/twitter.com\/CLD_Learning\/statuses\/849353647544827904","license":"gnip","citation_ids":[18492471],"posted_on":"2017-04-04T20:11:04+00:00","author":{"name":"ClinicalLiverDisease","url":"http:\/\/www.CLDLearning.com","image":"https:\/\/pbs.twimg.com\/profile_images\/742770496027131904\/WNDjsIFD_normal.jpg","description":"Clinical Liver Disease (CLD) is an official digital learning resource of The American Association for the Study of Liver Diseases.","id_on_source":"CLD_Learning","tweeter_id":"386256119","geo":{"lt":null,"ln":null},"followers":3747},"tweet_id":"849353647544827904"},{"url":"http:\/\/twitter.com\/clinicahigado\/statuses\/849355389384699905","license":"gnip","rt":["CLD_Learning"],"citation_ids":[18492471],"posted_on":"2017-04-04T20:17:59+00:00","author":{"name":"Guillermo Cabrera","url":"http:\/\/www.clinicadehigado.mx","image":"https:\/\/pbs.twimg.com\/profile_images\/753263889995866112\/MQaX4H-R_normal.jpg","description":"I\u00b4m physician involved in liver medical problems, we are making Clinical Trials in liver and GI diseases","id_on_source":"clinicahigado","tweeter_id":"72191492","geo":{"lt":18.94201,"ln":-99.22646,"country":"MX"},"followers":71},"tweet_id":"849355389384699905"},{"url":"http:\/\/twitter.com\/BruceSchackman\/statuses\/851581221763198977","license":"gnip","citation_ids":[18492471],"posted_on":"2017-04-10T23:42:39+00:00","author":{"name":"Bruce Schackman","image":"https:\/\/pbs.twimg.com\/profile_images\/657310793952841729\/FybXH8K0_normal.jpg","description":"Professor Healthcare Policy & Research @WCMhpr \r\nDirector @CHERISHresearch","id_on_source":"BruceSchackman","tweeter_id":"3723175821","geo":{"lt":40.71427,"ln":-74.00597,"country":"US"},"followers":185},"tweet_id":"851581221763198977"},{"url":"http:\/\/twitter.com\/contirena1\/statuses\/851901848449667072","license":"gnip","rt":["BruceSchackman"],"citation_ids":[18492471],"posted_on":"2017-04-11T20:56:42+00:00","author":{"name":"Rena Conti","image":"https:\/\/pbs.twimg.com\/profile_images\/794559279277703168\/YcofXdWl_normal.jpg","description":"Uofchicago professor, expert on pharmaceutical economics","id_on_source":"contirena1","tweeter_id":"4899299848","geo":{"lt":39.76,"ln":-98.5,"country":"US"},"followers":555},"tweet_id":"851901848449667072"}]}}